NetworkNewsBreaks – CytoDyn Inc. (CYDY) Interim CMO to Present at 11th Annual Conference on Stem Cell and Regenerative Medicine

CytoDyn Inc. (OTCQB: CYDY), a biotechnology company developing innovative treatments for multiple therapeutic indications, this morning announced that Richard G. Pestell, M.D., Ph.D., president of the Pennsylvania Cancer and Regenerative Medicine Research Center, distinguished professor at the Baruch S. Blumberg Institute and interim chief medical officer of CytoDyn, will deliver the keynote plenary speech at the 11th Annual Conference on Stem Cell and Regenerative Medicine in Helsinki, Finland. Pestell’s presentation, titled ‘Cancer stem cells, genetic drivers and therapeutic targeting via CCR5’, is scheduled to take place on Monday, October 15, from 10-11 am EEST. Pestell will present recent scientific evidence demonstrating the effectiveness of PRO 140 (leronlimab), which is shown to bind to CCR5 in human breast cancer, block CCR5 signaling induced by cytokines and block human breast cancer cell invasion.

To view the full press release, visit http://nnw.fm/SgzM0

About CytoDyn

CytoDyn is a biotechnology company developing innovative treatments for multiple therapeutic indications based on PRO 140 (leronlimab), a novel humanized monoclonal antibody targeting the CCR5 receptor. CCR5 plays a key role in the ability of HIV to enter and infect healthy T-cells.  The CCR5 receptor is also implicated in tumor metastasis and in immune-mediated illnesses such as graft-vs-host disease (GvHD) and NASH. CytoDyn has successfully completed a Phase 3 pivotal trial with PRO 140 in combination with standard anti-retroviral therapies in HIV-infected treatment-experienced patients. The Company plans to seek FDA approval for PRO 140 in combination therapy and plans to complete the filing of a Biological License Application (BLA) in the first quarter of 2019 for that indication. CytoDyn is also conducting a Phase 3 investigative trial with PRO 140 as a once-weekly monotherapy for HIV-infected patients, and plans to initiate a registration-directed study of PRO 140 monotherapy indication, which if successful, could support a label extension. Clinical results to date from multiple trials have shown that PRO 140 can significantly reduce viral burden in people infected with HIV with no reported drug-related serious adverse events (SAEs). Moreover, results from a Phase 2b clinical trial demonstrated that PRO 140 monotherapy can prevent viral escape in HIV-infected patients, with some patients on PRO 140 monotherapy remaining virally suppressed for more than four years. CytoDyn is also conducting a Phase 2 trial to evaluate PRO 140 for the prevention of GvHD and expects to initiate clinical trials with PRO 140 in metastatic triple-negative breast cancer in 2018. For more information, visit the company’s website at www.CytoDyn.com

More from NetworkNewsBreaks

NetworkNewsBreaks – FinCanna Capital Corp. (CSE: CALI) (OTCQB: FNNZF) Investee Adds Taxation Reporting Technology to its Proprietary Compliance Platform NetworkNewsBreaks – First Cobalt Corp. (TSX.V: FCC) (OTCQX: FTSSF) Announces Results of Independent Studies Supporting Restart of Canadian Refinery NetworkNewsBreaks – The Flowr Corporation (TSX.V: FLWR) Ships Initial Purchase Order from the NSLC

About NetworkNewsWire

NetworkNewsWire (NNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) NetworkNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. NNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.

To receive instant SMS alerts, text STOCKS to 77948

For more information please visit https://www.NetworkNewsWire.com

Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer

NetworkNewsWire (NNW)
New York, New York
www.NetworkNewsWire.com
212.418.1217 Office
Editor@NetworkNewsWire.com

NetworkNewsWire has received compensation from CytoDyn Inc. for providing certain investor relations, marketing and social media services, including the preparation of this report, and expects to receive additional compensation for such services in the future. This compensation includes a monthly program fee.

Latest News

Trump says climate change not a hoax, not sure of its source

Oct 15, 2018

WASHINGTON — President Donald Trump is backing off his claim that climate change is a hoax but says he doesn't know if it's manmade and suggests that the climate will "change back again." In an interview with CBS' "60 Minutes" that aired Sunday night, Trump said he doesn't want to put the U.S. at a disadvantage in responding to climate change. "I think something's happening. Something's changing and it'll change back again," he said. "I don't think it's a hoax. I think there's probably a difference. But I don't know that it's manmade. I will say this: I don't want...

Guatemala volcano spews ash months after deadly eruption

Oct 15, 2018

MEXICO CITY — Guatemala's Volcano of Fire spewed ash and lava Saturday just months after an eruption killed at least 110 people. The country's seismology and volcanology institute said hot lava was spilling from the crater and flowing toward a ravine. Constant rumblings from the volcano sounded like an engine, and columns of gray ash billowed 4,600 meters (15,091 feet) into the air. Authorities urged nearby residents to evacuate and be alert for possible lahars - flows of mud, debris, water and pyroclastic material - that could be fed by afternoon rains. The Volcano of Fire is one of the...

As sea ice melts, some say walruses need better protection

Oct 15, 2018

ANCHORAGE, Alaska — Given a choice between giving birth on land or sea ice, Pacific walrus mothers most often choose ice. Likewise, they prefer sea ice for molting, mating, nursing and resting between dives for food. Trouble is, as the century progresses, there's going to be far less ice around. How well walruses cope with less sea ice is at the heart of a legal fight over whether walruses should be listed as a threatened species, giving them an added protection against human encroachments. The federal government in 2008 listed polar bears as a threatened species because of diminished sea...

Life-sized plastic whale to raise ocean pollution awareness

Oct 15, 2018

SAN FRANCISCO — Artists are putting the finishing touches on an 82-foot-long (24-meter-long) blue whale made from discarded plastic that will be on display near San Francisco's Golden Gate Bridge to raise awareness about ocean pollution. The Monterey Bay Aquarium said Friday a blue whale can weigh 300,000 pounds (136,000 kilograms) — about the amount of plastic scientists say enters the ocean every nine minutes. A 2015 study by Jenna Jambeck, an environmental engineer at the University of Georgia, found 9 million tons (8 million metric tons) of plastic waste enter the ocean annually. The sculpture created from plastic water...

NASA official: Tense moments but calm crew in aborted launch

Oct 15, 2018

MOSCOW — NASA's chief heard one reassuring sound over the radio link after the aborted launch of a Soyuz capsule with an American and a Russian aboard. It was U.S. astronaut Nick Hague calmly relaying information in Russian to flight controllers. "My reaction was, 'things aren't going well and he's not speaking English,'" NASA Administrator Jim Bridenstine told reporters Friday, after Hague and Roscosmos' Alexei Ovchinin returned to the Star City training center outside Moscow from their abruptly shortened mission. "So, in other words, he was calm, he was cool, he was collected, he was doing what he was trained...

Broaden News

About Us

In-Depth Science delivers comprehensive and compelling news and analysis on everything science and technology, seven days a week in a reader-friendly format.

Contact us: sales@indepthscience.com